Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (1): 98-103    DOI: 10.12891/ceog3295.2017
Original Research Previous articles | Next articles
Pro-inflammatory and anti-inflammatory cytokine profiles in fetal growth restriction
M. Al-Azemi1, R. Raghupathy2, *(), F. Azizieh3
1 Department of Obstetrics & Gynecology, Faculty of Medicine, Kuwait University, Kuwait
2 Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait
3 Department of Mathematics and Natural Sciences, Gulf University for Science and Technology, West Mishref, Kuwait
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
The purpose of this investigation was to measure cytokine production by maternal peripheral blood lymphocytes from women with intrauterine growth restriction (IUGR) and from healthy pregnant women, and to investigate the relationship between cytokine profiles and IUGR. Thirty-six women with IUGR and 22 control healthy pregnant women with normal fetal growth were studied. Levels of pro-inflammatory cytokines (IFNγ, TNFα, IL-8, IL-12, IL-18, IL-23) and anti-inflammatory cytokines (IL-4, IL-10, IL-13) produced by mitogen-stimulated peripheral blood mononuclear cells were measured by ELISA. Levels of the anti-inflammatory cytokine IL-4 were higher in normal pregnancy compared to IUGR, indicating an anti-inflammatory bias. Levels of the pro-inflammatory cytokines IL-6, TNFα, and IL-12 were significantly higher and levels of the anti-inflammatory cytokine IL-10 lower in IUGR with placental insufficiency than in IUGR without placental insufficiency, suggesting a stronger pro-inflammatory bias in IUGR with placental insufficiency. Ratios of pro- to anti-inflammatory cytokines suggest a dominance of pro-inflammatory cytokines. The authors conclude that an increased pro-inflammatory cytokine bias is observed in IUGR compared to normal pregnancy, and an increased pro-inflammatory cytokine dominance is seen in IUGR with placental insufficiency compared to IUGR without placental insufficiency.
Key words:  Fetal growth restriction      Pro-inflammatory cytokines      Anti-inflammatory cytokines     
Published:  10 February 2017     
*Corresponding Author(s):  R. RAGHUPATHY     E-mail:  raj@hsc.edu.kw

Cite this article: 

M. Al-Azemi, R. Raghupathy, F. Azizieh. Pro-inflammatory and anti-inflammatory cytokine profiles in fetal growth restriction. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 98-103.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3295.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I1/98

[1] N. Wibowo, R. Irwinda, A.T. Rivai. Serum zinc, selenium, iron, and copper levels in pregnant women with fetal growth restriction[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 892-896.
[2] S. Magawa, H. Tanaka, S. Maki, M. Nii, T. Umekawa, T. Ikeda. Effects of tadalafil on the uterine artery of fetal growth restriction[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 833-835.
[3] Yajing Zhu, Hongmei Ma, Wei Ma. Transthyretin and retinol-binding protein 4 in patients with fetal growth restriction[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 270-273.
[4] H. Tanaka, S. Maki, M. Kubo, H. Yuasa, T. Umekawa, T. Ikeda. Treatment using tadalafil for dichorionic diamniotic twin pregnancy with fetal growth restriction[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 591-593.
No Suggested Reading articles found!